Virtus LifeSci Biotech Clinical Trials ETF (BBC) Holdings $18.09 -0.15 (-0.82%) As of 05/23/2025 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsRatingsBuy This Stock Top 100 BBC HoldingsRankCompanyCurrent PriceWeightShares Held1SLNOSoleno Therapeutics$76.89+4.1%1.88%2,8762XERSXeris Biopharma$4.83-1.0%1.66%39,1783AKROAkero Therapeutics$46.36-5.3%1.63%4,5924LQDALiquidia$15.35-1.3%1.63%12,1055SMMTSummit Therapeutics$25.85+0.3%1.61%7,4596ANABAnaptysBio$20.44-1.4%1.52%8,8697MLYSMineralys Therapeutics$15.96-2.2%1.40%10,9508ARQTArcutis Biotherapeutics$13.98+2.3%1.34%10,8819CVACCureVac$4.09-1.7%1.29%41,62410PTGXProtagonist Therapeutics$45.66-0.5%1.28%3,298 Get the Latest News and Ratings for BBC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. 11ETNB89bio$9.49-1.7%1.18%16,96812MRUSMerus$55.14+32.5%1.17%3,21913TSHATaysha Gene Therapies$2.75-3.5%1.17%59,19914SANASana Biotechnology$1.99-0.5%1.12%65,29615BLTEBelite Bio$61.00-5.6%1.11%2,10116LENZLENZ Therapeutics$28.17-0.2%1.09%4,32717ZYMEZymeworks$11.54+0.5%1.08%10,56018ABUSArbutus Biopharma$3.221.07%37,41319RVMDRevolution Medicines$39.77+2.5%1.06%2,96320MNMDMind Medicine (MindMed)$7.30+3.3%1.05%18,97521RGNXREGENXBIO$9.71-1.5%1.04%15,28322SVRASavara$2.84-3.1%1.03%39,76323XENEXenon Pharmaceuticals$29.75-2.4%1.03%3,37924APGEApogee Therapeutics$39.48-2.2%1.02%3,00625CMPSCOMPASS Pathways$4.36+4.3%1.01%30,21126PHVSPharvaris$15.99-2.4%1.01%7,00827RNAAvidity Biosciences$30.58-0.7%0.99%3,94428CGONCG Oncology$25.44-1.2%0.99%4,61829ITOSiTeos Therapeutics$8.56-1.5%0.99%16,76430QUREuniQure$15.16-0.5%0.99%8,85031DNTHDianthus Therapeutics$18.42+0.3%0.97%5,66932CELCCelcuity$10.44-2.9%0.96%10,57033NUVLNuvalent$73.49+0.4%0.96%1,53434Bny Mellon Cash Reserve UsdN/A0.95%111,13235ELVNEnliven Therapeutics$16.40-2.2%0.94%5,79436NUVBNuvation Bio$2.31+2.7%0.93%50,65337SNDXSyndax Pharmaceuticals$9.85-8.9%0.93%9,89338NGNENeurogene$17.28-4.2%0.90%5,96539BCAXBicara Therapeutics$9.27-40.8%0.89%7,38240CNTACentessa Pharmaceuticals$12.87+2.0%0.89%7,902$19 for a FULL YEAR of stock picks?! (Ad)Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock.Watch the exclusive AI investor briefing >>>41SRRKScholar Rock$30.00-1.5%0.89%3,19942STOKStoke Therapeutics$9.36-1.5%0.89%10,81743AVBPArriVent BioPharma$20.40-1.1%0.88%5,14944GPCRStructure Therapeutics$24.55-0.4%0.88%4,20345CLDXCelldex Therapeutics$20.35-0.1%0.87%5,03846KYMRKymera Therapeutics$29.49-2.3%0.87%3,15747NAMSNewAmsterdam Pharma$17.61-3.7%0.87%5,31448KROSKeros Therapeutics$14.57+2.9%0.85%7,23149MLTXMoonLake Immunotherapeutics$38.93+1.1%0.85%2,47550EYPTEyePoint Pharmaceuticals$5.68+1.4%0.84%16,77551IRONDisc Medicine$47.37-1.4%0.83%2,07452VRDNViridian Therapeutics$13.57-0.7%0.83%7,41153CATXPerspective Therapeutics$2.39-4.8%0.82%38,38454ACLXArcellx$63.92-2.0%0.81%1,59655IDYAIDEAYA Biosciences$18.82+0.7%0.81%5,17156OLMAOlema Pharmaceuticals$5.04-2.3%0.81%19,82357VIRVir Biotechnology$4.50-2.4%0.81%17,92558SLRNAcelyrin$2.270.80%37,62759ALTAltimmune$5.71-1.0%0.80%15,51560TRMLTourmaline Bio$15.32+0.3%0.80%5,91961ABCLAbCellera Biologics$1.97-1.5%0.79%45,15462VERVVerve Therapeutics$4.36-0.5%0.79%21,38163TYRATyra Biosciences$9.29-3.1%0.77%8,77664MREOMereo BioPharma Group$2.24-1.8%0.76%35,70565RXRXRecursion Pharmaceuticals$4.08-1.4%0.76%19,08066ARCTArcturus Therapeutics$12.20-4.7%0.75%7,59367BEAMBeam Therapeutics$16.83-2.4%0.74%4,75068CGEMCullinan Therapeutics$7.81-1.0%0.74%10,91769RLAYRelay Therapeutics$2.91+2.1%0.74%27,86870CYTKCytokinetics$30.54+0.2%0.73%2,65471ORICORIC Pharmaceuticals$6.35+6.7%0.73%15,79972REPLReplimune Group$8.35-4.7%0.73%10,90873ARWRArrowhead Pharmaceuticals$15.13-1.7%0.72%6,02174DNLIDenali Therapeutics$13.42-1.8%0.72%5,67675NTLAIntellia Therapeutics$9.16-3.2%0.72%9,82576KURAKura Oncology$5.64-9.6%0.72%13,75377SYRESpyre Therapeutics$15.01-0.4%0.71%5,57278COGTCogent Biosciences$4.82-2.6%0.70%15,97879IMTXImmatics$5.11-1.7%0.70%17,97480IMNMImmunome$8.49+0.4%0.69%10,19981CRNXCrinetics Pharmaceuticals$29.76-1.2%0.68%2,39782VKTXViking Therapeutics$26.98-2.7%0.67%2,78383ALLOAllogene Therapeutics$1.06-2.8%0.66%65,94284SLNSilence Therapeutics$5.06+4.5%0.66%20,18585PRTAProthena$6.58+0.5%0.63%9,64986RAPPRapport Therapeutics$10.82-2.7%0.63%7,01287RCKTRocket Pharmaceuticals$6.27-4.4%0.63%10,59388MBXMBX Biosciences$12.15-2.9%0.62%6,50089GLUEMonte Rosa Therapeutics$3.97-2.0%0.62%17,09890PRAXPraxis Precision Medicines$37.55-2.0%0.62%1,878Buffett’s $325 Billion Cash Problem — Solved by Gold? (Ad)A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late. Discover how you could front-run Buffett’s gold move with Garrett’s Top Four picks.91EWTXEdgewise Therapeutics$14.21+1.4%0.60%4,73492ERASErasca$1.22+0.8%0.60%50,65393IMVTImmunovant$14.46-0.7%0.60%4,82994RNACCartesian Therapeutics$9.16+0.1%0.59%6,62195RCUSArcus Biosciences$9.05+3.0%0.58%7,76796BHVNBiohaven$15.67+1.5%0.58%3,31797AUTLAutolus Therapeutics$1.54+0.7%0.57%49,52198CRVSCorvus Pharmaceuticals$3.49+0.6%0.57%16,48299VERAVera Therapeutics$19.64+0.1%0.57%2,951100CAPRCapricor Therapeutics$10.25-5.6%0.56%9,292 Geographic ExposureUnited States88.0%Netherlands2.7%Canada2.6%Cayman Islands0.8%Ireland0.5%Singapore0.5%Virgin Islands, British0.4%Currency ExposureUSD100.0%Sector ExposureHealth Care95.1%Energy1.3%Consumer Discretionary0.8%Industry ExposureBiotechnology82.6%Pharmaceuticals11.6%Diversified Consumer Services1.7%Renewable Energy1.3%SubIndustry ExposureBiotechnology78.9%Pharmaceuticals13.1%Renewable Energy Equipment1.3%Coupon Exposure0-21.1% Related Companies and Tools Related Companies PILL Portfolio MEDX Portfolio MEDI Portfolio JDOC Portfolio LGHT Portfolio GDOC Portfolio HYLG Portfolio FTXH Portfolio BIS Portfolio RXD Portfolio This page (NYSEARCA:BBC) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BBC Stock Free BBC Stock Alerts